"Colorectal Cancer - Pipeline Review, 2015" now available at Fast Market Research

From: Fast Market Research, Inc.
Published: Mon Nov 02 2015

GlobalData's Medical Devices sector report, "Colorectal Cancer - Pipeline Review, 2015" provides an overview of Colorectal Cancer diagnostic tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Colorectal Cancer diagnostic tests pipeline products.

Full Report Details at
- http://www.fastmr.com/prod/1063420_colorectal_cancer_pipeline.aspx?afid=301

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Report Scope

* Extensive coverage of the Colorectal Cancer diagnostic tests under development
* The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
* The report reviews the major players involved in the development of Colorectal Cancer diagnostic tests and list all their pipeline projects
* The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
* The report provides key clinical trial data of ongoing trials specific to pipeline products
* Recent developments in the segment / industry

Reasons to Get this Report

The report enables you to -

* Formulate significant competitor information, analysis, and insights to improve R&D strategies
* Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
* Identify and understand important and diverse types of Colorectal Cancer diagnostic tests under development
* Develop market-entry and market expansion strategies
* Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
* In-depth analysis of the product's current stage of development, territory and estimated launch date

Companies Mentioned in this Report: A2K Technologies, Abbott Diagnostics, Advanced Marker Discovery, S.L., Advpharma Inc., Ambergen, Inc., Ambrilia Biopharma Inc., Applied Proteomics, Inc., Arizona State University, ArtemixRx, Asuragen, Inc., Bio Mark Ltd, Biocartis SA, Biodesix Inc., BioMarCare Technologies Ltd., BioMark Diagnostics Inc., BioMark Technologies Inc., BioMarker Strategies, LLC, bioMerieux S.A., Biosceptre (Aust) Pty Ltd, BioSystems International, Biotechnostics GmbH, Biotron Limited, Castle Biosciences Incorporated, Cellmid Limited, Ceres Nanosciences, Inc., Cernostics Inc., ChemImage Corporation, China Sky One Medical, Inc., Chinese University of Hong Kong, Chronix Biomedical, Inc., Cleveland Diagnostics Inc., ColoPrev, Columbia University, Courtagen Life Sciences, Inc., CS-Keys, Inc., Dartmouth College, Di.V.A.L Toscana srl, diaDexus, Inc., DiagnoCure Inc., Diaxonhit S.A., EDP Biotech Corporation, Epigenomics AG, Eureka Genomics Corporation, Eventus Diagnostics, Inc., Exact Sciences Corporation, Exiqon A/S, Exosomics Siena SpA, Fina Biotech, GenomicTree, Inc., Ghent University, GlycoZym, Health Discovery Corporation, Human Metabolome Technologies, Inc., Ikonisys, Inc., Innovative Health Diagnostics, IntegraGen SA, InterGenetics Incorporated, IV Diagnostics, Inc., Lab21 Limited, Laboratorios Alpha San Ignacio Pharma S.L., LX Diagnostics, MabCure Inc., Matrix-Bio, Inc., Mayo Clinic, MDxHealth SA, Metabiomics Corporation, Metabolomic Technologies Inc., Metabolon, Inc., MetaStat, Inc., Milagen, Inc., Miraculins Inc., Mode Dx Ltd., Myriad Genetics, Inc., Nanosphere, Inc., Neogenix Oncology, Inc., NetScientific Plc, Norda ASA, Novel Bio-spectrum Technologies, Inc., Nuclea Biotechnologies Inc., Nuvera Biosciences, Inc., OncoVista Innovative Therapies, Inc., Origin Sciences Limited, Orion Genomics LLC, OTraces Inc., Oxford Cancer Biomarkers, Oxford Gene Technology Limited, Pacific Edge Limited, Panacea Pharmaceuticals, Inc., PleX Diagnostics, Prediction Sciences, Protagen AG, Rosetta Genomics, Ltd., Scienion AG, Seegene, Inc., Shuwen Biotech Co. Ltd., Siamab Therapeutics, Inc., Sienna Cancer Diagnostics Ltd, Skuldtech France, Sysmex Corporation, Tel Aviv University, Texas A&M University, The Johns Hopkins University, TheraDiag SA, Todos Medical, Universite De Lyon, University of Alabama at Birmingham, University of Chicago, University of Texas at Austin, US Biomarkers, Inc., Vanderbilt University, Vermillion, Inc., Viomics Inc., Vitatex Inc., VolitionRX Ltd., XEPTAGEN SpA

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Acquired Gene or Chromosome Alterations - Pipeline Review, 2015
- Pancreatic Cancer - Pipeline Review, 2015
- Ovarian Cancer - Pipeline Review, 2015
- Inborn Gene or Chromosome Alterations - Pipeline Review, 2015
- Cervical Cancer - Pipeline Review, 2015

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email: press@fastmr.com
Contact Phone: 1-413-485-7001

Visit website »